SureTrader
Home > Boards > US Listed > Cannabis > GW Pharmaceuticals Plc ADS (GWPH)

Breakout? Is there news somewhere that I am

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
erdos47 Member Profile
 
Followed By 4
Posts 2,135
Boards Moderated 0
Alias Born 11/25/03
160x600 placeholder
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006 GlobeNewswire Inc. - 2/21/2018 4:01:00 PM
Cannabinoids Lead to Marijuana Biotech Boom NetworkNewsWire - 2/13/2018 8:45:00 AM
Investment Opportunities in Advanced Bioengineered Drug Delivery NetworkNewsWire - 2/7/2018 8:45:00 AM
GW Pharmaceuticals to Present at the Leerink Partners 7th Annual Global Healthcare Conference on 14 February GlobeNewswire Inc. - 2/6/2018 11:35:58 AM
GW Pharmaceuticals Announces the European Medicines Agency (EMA) Accepts Epidiolex® (cannabidiol) Marketing Authorization Ap... GlobeNewswire Inc. - 2/5/2018 4:00:00 PM
GW Pharmaceuticals plc Reports Fiscal First Quarter 2018 Financial Results and Operational Progress GlobeNewswire Inc. - 2/5/2018 4:00:00 PM
GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 5 February, 2018 GlobeNewswire Inc. - 1/29/2018 1:00:00 PM
Fast-Growing Cannabis Industry Drives Biotech Research, Innovative Medical Therapy Development NetworkNewsWire - 1/25/2018 8:45:00 AM
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (Cannabidiol) S... PR Newswire (US) - 1/24/2018 6:30:00 PM
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (cannabidiol) S... GlobeNewswire Inc. - 1/24/2018 6:30:00 PM
GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the Treatment of Le... PR Newswire (US) - 12/29/2017 7:00:00 AM
GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the treatment of Le... GlobeNewswire Inc. - 12/29/2017 7:00:00 AM
GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndro... GlobeNewswire Inc. - 12/28/2017 7:00:00 AM
GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors GlobeNewswire Inc. - 12/21/2017 7:00:00 AM
Biotech Market Banking on Big Cannabis Returns NetworkNewsWire - 12/19/2017 8:45:00 AM
Dangerous Opioid Side Effects Shift Market Focus to Cannabis for Chronic Pain NetworkNewsWire - 12/13/2017 8:45:00 AM
GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S. GlobeNewswire Inc. - 12/13/2017 7:00:00 AM
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4 Million and Full Exe... GlobeNewswire Inc. - 12/11/2017 5:19:05 PM
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs Raising Gross Proceeds of $276 Million GlobeNewswire Inc. - 12/6/2017 9:40:30 PM
Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management NetworkNewsWire - 12/6/2017 8:45:00 AM
GW Pharmaceuticals Announces Proposed Public Offering of ADSs GlobeNewswire Inc. - 12/5/2017 4:01:00 PM
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress GlobeNewswire Inc. - 12/4/2017 7:00:00 AM
Investors Could Reap Global Rewards of Research into Medical Cannabis Science NetworkNewsWire - 11/30/2017 8:45:00 AM
GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 4 December, 2017 GlobeNewswire Inc. - 11/27/2017 7:00:00 AM
GW Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 11/22/2017 7:00:00 AM
erdos47   Wednesday, 07/19/17 09:43:55 AM
Re: None
Post # of 4918 
Breakout? Is there news somewhere that I am not seeing on etrade?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist